Report
Augustin Socié ...
  • Clément Bassat
  • Maxence Dhoury
  • Mohamed Kaabouni
  • Nicolas Royot

La Matinale - 2023-03-02 - Portzamparc

LA VALEUR DU JOUR :
BROADPEAK : Atterrissage en ligne, au-dessus de la guidance – Acheter (1), obj. 9.00€ Cours: 6.20€ au 01/03/23
BIOCORP : Lilly casse le prix de ses insulines – Acheter (1), obj. 38.0€ Cours: 23.1€ au 01/03/23
MITHRA : Explore les inhibiteurs de Tyrosine Kinase – Conserver (3) Cours: 2.39€ au 01/03/23
THERADIAG : Simon Davière, 11 ans chez Theradiag, est nommé DG – Conserver (3), obj. 2.20€ Cours: 2.16€ au 01/03/23
VALNEVA : Update réglementaire de VLA2001 – Acheter (1), obj. 10.7€ Cours: 5.47€ au 01/03/23
WAGA ENERGY : Le biométhane progresse mais le potentiel est immense – Renforcer (2), obj. 35.7€ Cours: 27.4€ au 01/03/23
COLLECTE / DECOLLECTE : Accalmie mais toujours pas de collecte
ET AUSSI : LACROIX, ARTEA, ROCTOOL…
Underlyings
Biocorp Production SA

Biocorp Production SA is a France-based company, which is specialised in the development and manufacturing of medical and drug delivery devices.

N.V. Mithra Pharmaceuticals S.A.

Mithra Pharmaceuticals SA is a Belgium-based company active in the pharmaceutical industry. The Company is dedicated to provide products and services for the fertility, contraception and menopause of women. It has a number of patent families regarding Estetrol (E4), a natural estrogen produced by the human foetus, which enables the investigation of fertility and contraception products. Mithra is focused on the development of two late-stage E4-based products: Estelle, a 5th generation oral contraceptive, and Donesta, a hormone therapy for Vasomotor Symptoms in menopause. Mithra develops a contraceptive vaginal ring called Myring and Zoreline, a biodegradable subcutaneous implant for hormone dependant cancer.

Theradiag SA

Theradiag SA is a France-based company which develops and markets biological diagnostic tools. The Company develops and offers product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. TheraDiags product offering consists of tests using a range of techniques (Elisa, rapid tests, immunofluorescence, Dot, immunochemical tests, molecular biology, etc.) as well as a range of automatic devices and solutions for high-speed diagnostics based on Luminexs Multiplex technology. It has also developed a range of theranostic diagnostics commercialized under the Lisa-Tracker brand which provide monitoring of patients treated by anti-TNF monoclonal antibodies. TheraDiag is active in more than 30 countries, as an independent distributor.

Valneva SE

Valneva, together with its subsidiaries, is focused on vaccine development and antibody discovery. Co. generates revenue from both its marketed product, a vaccine for the prevention of Japanese encephalitis (IXIARO®/JESPECT®), commercial partnerships around a portfolio of product candidates and licensed technology platforms (EB66® cell line, VIVA,Screen antibody discovery technology, and the IC31® adjuvant) developed by Co. Related business activities include product research and development, regulatory and clinical activities, manufacturing of commercial product and advanced clinical product candidates, as well as administrative, corporate development, and marketing and sales activities.

WAGA ENERGY SA

Provider
Portzamparc Sponsored
Portzamparc Sponsored

​Portzamparc is a subsidary of BNP Paribas which adapted the mission to contribute to responsible and sustainable growth of private clients, management companies and SMEs . They offer personalized support adapted to the objectives in particular for Small and Medium-Sized Enterprises.

Analysts
Augustin Socié

Clément Bassat

Maxence Dhoury

Mohamed Kaabouni

Nicolas Royot

Other Reports on these Companies
Other Reports from Portzamparc Sponsored

ResearchPool Subscriptions

Get the most out of your insights

Get in touch